AstraZeneca PLC

Crypto tech vs. COVID-19: How hospitals are using blockchain in the vaccine rollout

12:36 p.m. Jan. 20, 2021

- Jack Denton

Open all hours: Round-the-clock vaccination sites to be piloted in England in COVID-19 drive

3:31 p.m. Jan. 19, 2021

- Lina Saigol

Fauci says two more COVID-19 vaccines could be approved within ‘weeks’

2:49 a.m. Jan. 18, 2021

Why Indonesia is vaccinating its working-age adults before the elderly

10:54 a.m. Jan. 14, 2021

Under-owned and cheap: Why Barclays has turned more bullish on U.K. stocks

10:41 a.m. Jan. 13, 2021

- Barbara Kollmeyer

Pound climbs as Bank of England governor pushes back against negative interest rates

9:18 a.m. Jan. 12, 2021

- Jack Denton

AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower

9:00 a.m. Jan. 8, 2021

- Steve Goldstein

Slaoui proposes half-doses of Moderna’s COVID-19 vaccine to speed vaccinations

7:25 a.m. Jan. 5, 2021

- Jaimy Lee

U.S. heads toward 21 million COVID-19 cases and 353,000 deaths as vaccine program continues to lag all targets

2:56 p.m. Jan. 4, 2021

- Ciara Linnane

U.K. becomes first country to roll out AstraZeneca-Oxford vaccine as tighter lockdowns imminent

12:50 p.m. Jan. 4, 2021

Mining sector drives big rally for FTSE 100 as gold and other metals surge

5:52 a.m. Jan. 4, 2021

- Steve Goldstein

Optimism continues into new year as European stocks advance

4:39 a.m. Jan. 4, 2021

- Steve Goldstein

U.K. is in the ‘eye of the storm’ as coronavirus cases surge

6:44 p.m. Jan. 1, 2021

- Associated Press

European markets down on new COVID restrictions worries

10:08 a.m. Dec. 31, 2020

U.K. now has enough vaccine ‘to cover the entire population’ after authorization of AstraZeneca–Oxford COVID-19 vaccine

9:37 a.m. Dec. 31, 2020

- Jack Denton

Dow rings in another closing record as 2020 winds down

4:25 p.m. Dec. 30, 2020

- William Watts

London markets tread water as Parliament approves post-Brexit trade deal

10:40 a.m. Dec. 30, 2020

- Jack Denton

U.K. approves coronavirus vaccine AstraZeneca made with Oxford

6:47 a.m. Dec. 30, 2020

- Steve Goldstein

UPDATE: Coronavirus tally: Global cases of COVID-19 top 82 million as U.K. authorizes third vaccine

6:37 a.m. Dec. 30, 2020

- Ciara Linnane

Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations

6:35 a.m. Dec. 30, 2020

- Ciara Linnane

Roche’s Immunotherapy Drug Extended Patients’ Lives

9:20 p.m. Dec. 7, 2017

- The Wall Street Journal Interactive Edition

In U.K., Barriers Rising Against Foreign Deals

9:28 a.m. May 11, 2015

- The Wall Street Journal Interactive Edition

Celgene Profit Surges, Driven by Revlimid Sales

7:18 a.m. April 30, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Reports Fall in First-Quarter Profit

7:26 a.m. April 24, 2015

- The Wall Street Journal Interactive Edition

Billion-Dollar Health Startups

4:21 p.m. Feb. 27, 2015

- The Wall Street Journal Interactive Edition

Valeant to Buy Salix for About $10 Billion

8:44 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

3:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Valeant Nears Deal to Buy Salix

1:58 p.m. Feb. 22, 2015

- The Wall Street Journal Interactive Edition

Actavis Changing Name to Allergan

11:24 a.m. Feb. 18, 2015

- The Wall Street Journal Interactive Edition

Pharma Must Launch Itself Back

7:17 p.m. Feb. 16, 2015

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

11:42 p.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Deals Up a Tricky 2015

11:55 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

Pfizer to Buy Hospira for $16 Billion

10:22 a.m. Feb. 6, 2015

- The Wall Street Journal Interactive Edition

Astra to Buy Actavis Portfolio

6:54 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

New Outsourcing Frontier in India: Monitoring Drug Safety

10:20 p.m. Feb. 2, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca to Harness Benefits of Genome-Editing Technology

6:06 a.m. Jan. 29, 2015

- The Wall Street Journal Interactive Edition

Pfizer Sales Hit by Stronger Dollar

9:53 p.m. Jan. 27, 2015

- The Wall Street Journal Interactive Edition

Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug

5:07 p.m. Jan. 26, 2015

- The Wall Street Journal Interactive Edition

Peter Wallenberg Dies at 88

3:26 p.m. Jan. 19, 2015

- The Wall Street Journal Interactive Edition

Pharma Grows Itself a New Challenge -- Overheard

6:51 p.m. Jan. 13, 2015

- The Wall Street Journal Interactive Edition